News and Updates
Hamamatsu joins Seed Financing of QART Medical
Hamamatsu Photonics K.K., has joined Chartered Investment Managers, a SEA-based investment management fund, the Tel Aviv University (T.A.U), Technology Innovation Momentum Fund, managed by Ramot, TAU’s Business Engagement Center and a group of angel investors, in the Seed financing round, having an initial closing on March 2019.
Read moreQART Medical to Present in ECA 2018
QART Medical’s work on the assessment of DNA fragmentation of individual, unstained human sperm cells, has been accepted for presentation in the 10th Congress of the European Academy of Andrology (EAA). The congress will be held in Budapest, Hungary between October 11-13, 2018.
Read moreResearch on Stain-Free Sperm DNA Fragmentation Has Been Accepted for Publication
According to CDC’s 2016 Fertility Clinic Success Rates Report, there were 263,577 ART (assisted reproduction technology) cycles performed at 463 reporting clinics in the U.S during 2016, resulting in 65,996 live births, which is 1 out of 4 cycles (source: https://www.cdc.gov/art/artdata/index.html). Recent data consistently demonstrate a significant increase in miscarriage in patients with high DNA damage (i.e. fragmentation) compared with those with low DNA damage.
Read moreQART Medical receives notice of EU allowance on patent covering its compact module
Q-ART Medical announces today that its European patent application, named "Portable Interferometric Device" to Shaked et al. has been allowed. The patent teaches the realization of a novel, simple to use, portable, compact and inexpensive platform for interferometric optical thickness measurements that can be easily incorporated into an existing microscopes with integrated cameras.
Read moreU.S. Births Dip To 30-Year Low; Fertility Rate Sinks Further Below Replacement Level
Read moreCongratulations to the 2018 CYTO Innovation Technology Showcase Winner!
2018 CYTO Innovation Technology Showcase Winner
Read more